Per hour, HMD is producing over 4.2 lakh assorted syringes of which 1.4 lacs are AD Syringes
Hindustan Syringes & Medical Devices (HMD) has achieved its target commitment to creating capacities to produce over 1 billion AD syringes for covid vaccination per year to support the massive vaccination campaign to eradicate COVID-19 and help make India Atmanirbhar. It has also achieved the milestone of producing over 1 crore pieces of the assorted size of syringes daily.
Rajiv Nath, MD, Hindustan Syringes & Medical Devices said, “We are delighted that HMD has simultaneously reached two significant milestones towards Aatmanirbhar Bharat. HMD’s top priority right now is to help the government to combat the pandemic. HMD had been ensuring continuity of the supply chain and its manufacturing plants to ensure no shortages in India in India for its critically needed disposable devices during the covid crisis.”
HMD has made India proud with its global recognition as a key international supplier of critically needed syringes to COVAX facility of WHO (via UNICEF), Brazil and even Japan for Covid Vaccination while being on track and timely supplying the four orders received from GoI on 0.5 ml AD syringes totalling 44.25 crore pieces of which 36.5 crore pieces has been timely supplied by July end to help in vaccinating India against covid and balance by September.
Last year in December, HMD has also already dispatched 14 crore AD syringes to the COVAX stockpile Facility created in anticipation of supporting the global worldwide Vaccination Drive.
“This is in addition to our ongoing global contractual commitments to support global vaccination projects for 0.1 ml & 0.5 ml AD Kojak syringes in developing world whether for Yellow Fever or Measles or Hepatitis B or Pentavalent or BCG etc in addition to covid vaccination requirements of 0.3ml AD syringes for Pfizer’s vaccines. However, this year our focus is India as our countrys’ needs come first. We have reserved over 2/3rd capacity for India and continue to decline orders from many overseas new potential buyers,” said Rajiv Nath.
Over 440 million syringes will be supplied by HMD for India’s massive vaccination drive by September of which 365 million were timely supplied till July this year alongside supplies of Dispovan to the Private Hospitals and Vaccination Clinics.
